AI In Oncology For Analytical Solutions Market Report 2026

AI In Oncology For Analytical Solutions Market Overview

• AI In Oncology For Analytical Solutions market size has reached to $1.44 billion in 2025 • Expected to grow to $6.26 billion in 2030 at a compound annual growth rate (CAGR) of 34.2% • Growth Driver: Rising Cancer Prevalence Fuels Growth Of AI In Oncology For Analytical Solutions Market • Market Trend: Advancements In AI For Oncology Focus On Real-World Data Platforms • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under AI In Oncology For Analytical Solutions Market?

AI in oncology for analytical solutions refers to the use of artificial intelligence (AI) technology in the field of oncology to develop advanced analytical solutions for cancer research, diagnosis, and treatment. It helps healthcare professionals make data-driven decisions, improve diagnostic accuracy, and tailor treatment plans. The main types of components in AI in oncology for analytical solutions are data licensing services, software solutions, analytics, and others. Data licensing refers to the process of granting or obtaining legal permission to use and access data, typically through a contractual agreement between the data provider (licensor) and the data user (licensee). It includes treatment types such as chemotherapy, radiotherapy, immunotherapy, and other treatments. It is used in various cancer types, including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, kidney cancer, non-hodgkin lymphoma, and bladder cancer.

What Is The AI In Oncology For Analytical Solutions Market Growth Forecast?

The ai in oncology for analytical solutions market size is expected to see exponential growth in the next few years. It will grow to $6.26 billion in 2030 at a compound annual growth rate (CAGR) of 34.2%. The growth in the forecast period can be attributed to advancements in ai algorithms for oncology, expansion of oncology data licensing services, increasing integration of ai with genomic data, rising adoption of clinical decision support software, growing collaboration between healthcare providers and ai solution vendors. Major trends in the forecast period include increasing adoption of AI-based imaging and diagnostic software, rising use of predictive analytics in oncology research, expansion of clinical decision support systems for treatment planning, growing integration of genomic data with cancer treatment solutions, increasing demand for data licensing and analytics services.

Global AI In Oncology For Analytical Solutions Market Segmentation

1) By Component: Data Licensing Services, Software Solutions, Analytics and Other Services 2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-Hodgkin Lymphoma, Bladder Cancer 3) By Application: Diagnostic And Screening, Prognostic And Risk Stratification, Treatment Planning And Clinical Decision Support, Biomarker Discovery And Drug Development Subsegments: 1) By Data Licensing Services: Oncology Data Licensing, Genomic Data Licensing 2) By Software Solutions: AI-Based Imaging Software, Diagnostic Software, Clinical Decision Support Software 3) By Analytics And Other Services: Predictive Analytics Services, AI Training And Support Services, Data Analysis Services

What Is The Driver Of The AI In Oncology For Analytical Solutions Market?

The rising prevalence of cancer is expected to propel the growth of AI in oncology for the analytical solutions market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. AI in oncology for analytical solutions is used in cancer care to provide personalized treatment, early detection, and improved patient outcomes due to its ability to process large amounts of complex data quickly and efficiently. For instance, in May 2024, according to the National Cancer Institute, a US-based Government agency, in 2024, approximately 2 million new cancer cases are expected to be diagnosed in the US, with over 611,000 deaths projected. By 2040, new cancer cases are estimated to rise to 29.9 million globally, with cancer-related deaths increasing to 15.3 million. Therefore, the rising prevalence of cancer is driving the AI in oncology for analytical solutions industry.

Key Players In The Global AI In Oncology For Analytical Solutions Market

Major companies operating in the ai in oncology for analytical solutions market are IBM Watson Health, NVIDIA Corporation, Siemens Healthineers, GE Healthcare, Tempus, DeepMind Health, Paige.AI, PathAI, Aidoc, Nucleai, OWKIN, SOPHiA Genetics, Imagen Technologies, Atomwise, Enlitic, Inspirata, 3Scan, Zebra Medical Vision, Ibex Medical Analytics, Vuno Inc., Proscia, Google Health, Huiying Medical

Global AI In Oncology For Analytical Solutions Market Trends and Insights

Major companies operating in the AI in oncology for analytical solutions market are focusing on the development of AI advancements, such as new real-world data platforms to accelerate cancer research and advance generative AI models in oncology. A real-world data platform refers to a system that integrates and manages observational data from various sources outside of typical clinical research settings, such as electronic health records, health insurance claims, patient surveys, and disease registries. For instance, in October 2023, the Central Ohio Transit Authority, a US-based company, launched Vista, a new real-world data platform to speed up cancer research and enhance generative AI models in oncology. This platform intends to provide a more complete and uniform approach to managing cancer research data by merging several databases, including the data portal database and the genomic database. Additionally, Vista is expected to facilitate data sharing, improve data quality, and support various applications in the field of oncology and other areas of healthcare.

What Are Latest Mergers And Acquisitions In The AI In Oncology For Analytical Solutions Market?

In December 2023, ConcertAI, an India-based developer of medical research, acquired CancerLinQ for an undisclosed amount. This acquisition aims to build the leading healthcare learning and research network in oncology and provide members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions for accelerated clinical trials. CancerLinQ is a US-based cancer treatment company providing AI-based data and analytics.

Regional Outlook

North America was the largest region in the AI In oncology for analytical solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the AI In Oncology For Analytical Solutions Market?

The AI in oncology for analytical solutions market consists of revenues earned by entities by providing services such as consulting services, implementation services, training services, medical imaging analysis services, genomic data interpretation services, and drug discovery and development solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in oncology for analytical solutions market also includes sales of AI-powered imaging tools, drug discovery and development devices, and recurrence monitoring systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Oncology For Analytical Solutions Market Report 2026?

The ai in oncology for analytical solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in oncology for analytical solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.